LEADER 01491nam  2200433   450 
001 9910830189803321
005 20230203031532.0
010   $a1-119-63463-6
010   $a1-119-63464-4
010   $a1-119-63461-X
035   $a(MiAaPQ)EBC6837886
035   $a(Au-PeEL)EBL6837886
035   $a(CKB)20343336900041
035   $a(OCoLC)1291314834
035   $a(EXLCZ)9920343336900041
100   $a20220903d2022      uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPharmaceutical dissolution testing, bioavailability, and bioequivalence $escience, applications and beyond /$fUmesh V. Banakar
210  1$aHoboken, New Jersey :$cJohn Wiley & Sons, Inc.,$d[2022]
210  4$dİ2022
215   $a1 online resource (563 pages)
311 08$aPrint version: Banakar, Umesh V. Pharmaceutical Dissolution Testing, Bioavailability, and Bioequivalence Newark : John Wiley & Sons, Incorporated,c2022 9781119634607 
606   $aDrugs$xSolubility$xTesting
606   $aDrugs$xPrescribing
615  0$aDrugs$xSolubility$xTesting.
615  0$aDrugs$xPrescribing.
676   $a615.1901
700   $aBanakar$b Umesh V.$f1956-$01674880
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910830189803321
996   $aPharmaceutical dissolution testing, bioavailability, and bioequivalence$94039982
997   $aUNINA